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ABSTRACT Among the endemic deep mycoses in Latin America, paracoccidioido-
mycosis (PCM), caused by thermodimorphic fungi of the Paracoccidioides genus, is a
major cause of morbidity. Disease development and its manifestations are associated
with both host and fungal factors. Concerning the latter, several recent studies have
employed the methodology of gene modulation in P. brasiliensis using antisense
RNA (AsRNA) and Agrobacterium tumefaciens-mediated transformation (ATMT) to identify
proteins that inﬂuence fungus virulence. Our previous observations suggested that
paracoccin (PCN), a multidomain fungal protein with both lectin and enzymatic ac-
tivities, may be a potential P. brasiliensis virulence factor. To explore this, we used
AsRNA and ATMT methodology to obtain three independent PCN-silenced P. brasiliensis
yeast strains (AsPCN1, AsPCN2, and AsPCN3) and characterized them with regard to
P. brasiliensis biology and pathogenicity. AsPCN1, AsPCN2, and AsPCN3 showed rela-
tive PCN expression levels that were 60%, 40%, and 60% of that of the wild-type
(WT) strain, respectively. PCN silencing led to the aggregation of fungal cells,
blocked the morphological yeast-to-mycelium transition, and rendered the yeast less
resistant to macrophage fungicidal activity. In addition, mice infected with AsPCN1,
AsPCN2, and AsPCN3 showed a reduction in fungal burden of approximately 96%
compared with those inoculated with the WT strain, which displayed a more exten-
sive destruction of lung tissue. Finally, mice infected with the PCN-silenced yeast
strains had lower mortality than those infected with the WT strain. These data dem-
onstrate that PCN acts as a P. brasiliensis contributory virulence factor directly affect-
ing fungal pathogenesis.
IMPORTANCE The nonexistence of efﬁcient genetic transformation systems has
hampered studies in the dimorphic fungus Paracoccidioides brasiliensis, the etiologi-
cal agent of the most frequent systemic mycosis in Latin America. The recent devel-
opment of a method for gene expression knockdown by antisense RNA technology,
associated with an Agrobacterium tumefaciens-mediated transformation system, pro-
vides new strategies for studying P. brasiliensis. Through this technology, we gener-
ated yeasts that were silenced for paracoccin (PCN), a P. brasiliensis component that
has lectin and enzymatic properties. By comparing the phenotypes of PCN-silenced
and wild-type strains of P. brasiliensis, we identiﬁed PCN as a virulence factor whose
absence renders the yeasts unable to undergo the transition to mycelium and
causes a milder pulmonary disease in mice, with a lower mortality rate. Our report
highlights the importance of the technology used for P. brasiliensis transformation
and demonstrates that paracoccin is a virulence factor acting on fungal biology and
pathogenesis.
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Among the endemic deep mycoses having impact on public health in Latin America(1), paracoccidioidomycosis (PCM), caused by thermodimorphic fungi of the Para-
coccidioides genus, is a major source of morbidity (2). About 80% of the reported cases
occur in Brazil, with an estimated 3,360 new cases per year; most of the remaining cases
occur in Venezuela, Colombia, and Argentina (3, 4). PCM is caused by the thermally
dimorphic fungi Paracoccidioides brasiliensis and by P. lutzii species (5, 6), whose
conidia, produced in the mycelial phase, are inhaled by humans. After reaching the
pulmonary alveolar epithelium, the propagules transform into the parasitic yeast form
(7). Pulmonary lesions can lead to impairment of lung function and permanent inter-
ference with the patient’s quality of life. The disease can subsequently disseminate to
other organs, producing secondary injuries to mucosa, skin, lymphoid tissue, and
adrenal glands. Acute and subacute disease develops within weeks to months and
causes hypertrophy of the reticuloendothelial system. The chronic disease, which
accounts for more than 90% of cases, primarily affects the lungs and progresses slowly,
taking months to years to fully develop. In the absence of an effective therapy, it can
be lethal (8–10).
Disease manifestation is associated with host factors such as susceptibility and
immune status (2, 11) and with fungal factors such as virulence and pathogenicity (7,
12). Several studies that have been conducted have been aimed at identifying protein
components from P. brasiliensis that are relevant to fungal infection and pathogenicity.
Recent studies have employed a new gene modulation technique that allows insertion
of a target DNA sequence into the fungal genome of P. brasiliensis using Agrobacterium
tumefaciens-mediated transformation (ATMT) with transfer DNA (T-DNA) binary vectors
(13).
Based on our previous data, paracoccin (PCN) might also be considered to be among
the P. brasiliensis proteins that are candidate virulence factors. PCN is a multidomain
protein with both lectin and enzymatic activities that can bind N-acetylglucosamine
(14) and chitin but can also act as an N-acetylglucosaminidase (15). These biological
activities may potentially explain the role of PCN in fungal cell growth (16). PCN is also
able to act as an immunomodulatory agent when injected subcutaneously into P. brasil-
iensis-infected mice. This effect was suggested to be associated with the interaction of
PCN with TLR N-glycans and the induction of M1 polarization in macrophages and the
subsequent development of Th1 immunity (17–19).
Given the potential relevance of PCN, we aimed to study the role of PCN in
P. brasiliensis pathogenesis using antisense RNA (AsRNA) and the ATMT methodology.
We created PCN-deﬁcient P. brasiliensis mutant strains (AsPCN mutants) which were
mitotically stable and determined the level of mRNA and protein reduction in these
mutants. We showed that PCN silencing did not affect cell viability or growth but
instead reduced yeast cell separation. In addition, the morphological transition from
yeast to mycelium was blocked in the AsPCN mutants. Our data showed that PCN did
not contribute to fungal adherence to lung epithelial cells but instead rendered yeast
more susceptible to macrophage fungicidal activity. Furthermore, in mice infected with
PCN-silenced yeast, the disease caused by inoculation was milder than that caused by
the WT P. brasiliensis yeast. In summary, gene silencing of PCN revealed that paracoccin
is a P. brasiliensis virulence factor and contributes to its pathogenicity.
RESULTS
Generation of P. brasiliensis mutant strains. The role of PCN in stimulating
P. brasiliensis growth was suggested ﬁrst by the inhibitory effect of anti-paracoccin
antibodies in yeast cultures (16). To perform a broader study on the relevance of PCN
in fungal biology and virulence, we choose to silence PCN in P. brasiliensis using an
antisense RNA (AsRNA) methodology. We used transfer DNA (T-DNA) containing two
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different AsRNA sequences derived from the PCN gene, under the control of the RHO2
promoter. P. brasiliensis clones (referred to as strains AsPCN1 and AsPCN2) were
obtained by transformation with T-DNA containing the AS1 sequence, and strain
AsPCN3 was generated with the AS2 sequence. The T-DNA was inserted into P. brasil-
iensis wild-type (WT) strain 18 through Agrobacterium tumefaciens-mediated transfor-
mation (ATMT). After the mitotic stability process was performed, three independent
hygromycin-resistant (HR) clones, AsPCN1, AsPCN2, and AsPCN3, were selected, and
hygromycin resistance gene (HPH) ampliﬁcation conﬁrmed the presence of T-DNA.
These data demonstrate the efﬁciency of T-DNA transformation in generating P. brasil-
iensis clones to downregulate PCN expression.
Downregulation of PCN from P. brasiliensis. To demonstrate that the AsPCN1,
AsPCN2, and AsPCN3 mutant strains have differential levels of expression of the PCN
mRNA compared to the WT strain, we investigated the relative levels of expression of
PCN mRNA by quantitative real-time PCR (qRT-PCR). The AsPCN1, AsPCN2, and AsPCN3
strains showed reductions of levels of PCN mRNA of approximately 60%, 40%, and 60%,
respectively (Fig. 1A). In addition, we analyzed the silencing effect in all three AsPCN
mutant strains by measuring total cellular N-acetyl--D-glucosaminidase activity, a
known enzymatic activity of PCN (15). The enzyme activity of AsPCN cell lysates was
signiﬁcantly lower than that of the lysate from the WT strain (Fig. 1B) and was close to
the level seen with the negative control, indicating the PCN silencing. We also evalu-
ated the efﬁciency of PCN silencing by analyses of Western blotting. Yeast cells were
harvested from cultures by centrifugation at 5,000  g and 25°C for 5 min and were
disrupted by sonication, according to a previously reported protocol (20). Through a
Western blotting procedure, electrophoresed components of the yeast lysates were
transferred to a membrane and reacted with the anti-PCN antibody. A labeled second-
FIG 1 PCN silencing in P. brasiliensis yeasts. (A) The relative PCN expression levels in the transformed clones (AsPCN1,
AsPCN2, and AsPCN3) were determined by qRT-PCR and compared to the expression detected in WT P. brasiliensis, which
was set at 100%. The -actin and -tubulin reference genes were used as endogenous controls to normalize the relative
PCN expression levels. ***, signiﬁcant differences compared to WT P. brasiliensis (P  0.0001). (B) Crude extracts of yeast
cells from WT and AsPCN P. brasiliensis strains, cultured in DMEM, were assessed for NAGase (N-acetyl-beta-D-
glucosaminidase) activity, detected by the degradation of the NP-GlcNAc substrate. ***, signiﬁcantly different compared
to WT strain (P  0.001). OD405nm, optical density at 405 nm; Ctrl, control. (C) Graphic representation of Western blotting
images captured to determine the percentage of PCN-silencing, after normalization with -actin. The graphic was
generated by analysis ofﬂine using the software ImageJ. (D) Western blotting analysis of the PCN content in soluble
antigens of yeast cells obtained from WT, EV, and PCN-deﬁcient (AsPCN1, AsPCN2, AsPCN3) P. brasiliensis strains.
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ary antibody developed the reactions. There was reduced staining of the PCN 27-kDa
band in the material from all three mutated yeasts compared to the WT and EV (empty
vector) strains (Fig. 1C and D). In summary, all three of these analyses conﬁrmed the
efﬁciency of PCN knockdown in the AsPCN1, AsPCN2, and AsPCN3 mutant strains.
PCN silencing alters the growth characteristics of P. brasiliensis. To better
understand the effect of PCN on P. brasiliensis yeast growth, AsPCN1, AsPCN2, AsPCN3,
WT, and EV strains were grown in Dulbecco’s modiﬁed Eagle’s medium (DMEM) at 37°C
for 9 days. Since all cultures reached the stationary-growth phase by 216 h, as
monitored by cell counting in optical microscopy, we conclude that the growth of the
AsPCNmutant strains is similar to the WT strain growth (Fig. 2). To evaluate levels of cell
viability among the different strains, cells were stained with diacetate ﬂuorescein-
ethidium bromide at the beginning of growth (0 h) and after 192 h of growth; all strains
had similar levels of cell viability. In spite of these similarities, the growth patterns
differed between the AsPCN mutant strains and the WT strain since the mutant cells
were more agglomerated than the WT cells. From this, we conclude that the PCN
silencing did not affect the growth of P. brasiliensis but led to agglomeration of the
fungal cells.
PCN silencing inhibits the yeast-to-mycelium transition. We evaluated morpho-
logically the yeast-to-mycelium (Y¡ M) transition of the AsPCN1, AsPCN2, and AsPCN3
mutant strains compared to the EV strain. For this purpose, strains were grown at 25°C
in liquid medium for the microscopic analysis of fungal cell morphology. The cells
grown were analyzed by ﬂuorescence microscopy after calcoﬂuor white staining. At all
time points in the observation period, the AsPCN1, AsPCN2, and AsPCN3 strains grew
similarly; the cells assumed the elongated morphology of pseudohyphal forms (Fig. 3).
In contrast, the EV strain underwent complete Y¡ M conversion, exhibiting conidia in
the apical regions of hyphae 10 days after inoculation. From this, we conclude that PCN
is important in the mycelium conversion process.
PCN silencing favors P. brasiliensis susceptibility to killing by macrophages. To
assess PCN involvement in the interaction of P. brasiliensis with host cells, the capacity
of AsPCN mutant strains to adhere to A549 lung epithelial cells was compared with
ability of the WT strain to do the same. After 2 h of cell contact, the efﬁciencies of yeast
cell adherence to epithelial cells, as estimated by CFU counting, did not differ between
the AsPCN mutant strains and the WT strain (Fig. 4A). The involvement of PCN in
P. brasiliensis interactions with phagocytes was evaluated by coculturing AsPCN1,
AsPCN2, AsPCN3, EV, or WT strains with murine peritoneal macrophages. Using optical
microscopy to counting yeast cells in a Neubauer chamber, after disruption of macro-
phages, we observed that all yeast strains were similarly phagocytosed by macro-
phages after 4 h of coculture (Fig. 4B). We conclude that PCN does not play a role in
macrophage phagocytosis of P. brasiliensis. To examine whether PCN is relevant in
P. brasiliensis sensitivity to macrophage killing, we measured yeast cell recovery using
FIG 2 Growth of P. brasiliensis yeasts from WT, EV, and PCN-deﬁcient strains. Yeasts from WT, EV, and
PCN-deﬁcient (AsPCN1, AsPCN2, and AsPCN3) strains were cultivated in DMEM at 37°C for 9 days. Growth
curve proﬁles were determined by counting of yeasts by optical microscopy, using Neubauer chambers.
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a CFU assay of lysates from murine macrophages obtained after 48 h of incubation with
AsPCN1, AsPCN2, AsPCN3, or the WT strain. We found that a reduced number of colonies
were recovered from macrophages infected with the AsPCN mutant strains compared
to the WT strain (Fig. 4C). Taken together, these results demonstrate that PCN silencing
does not affect the early phases of infection of host cells by P. brasiliensis but instead
is important in resistance to macrophage killing. This observation suggests that PCN
may act as a P. brasiliensis virulence factor.
Murine infection with PCN-silenced mutant yeasts causes reduced tissue fun-
gal burden and pulmonary injury. We then evaluated whether the course of exper-
imental paracoccidioidomycosis could be inﬂuenced by PCN silencing in the infectious
yeast strain. We inoculated BALB/c mice with AsPCN1, AsPCN2, or AsPCN3 or with the
WT yeast strain via the intranasal route. At 30 days postinfection, CFU analysis of the
lung revealed a decreased fungal burden in the mice that were infected with AsPCN1,
AsPCN2, or AsPCN3 compared to those mice infected with WT yeast. The lungs of the
mice that were infected with AsPCN mutant strains exhibited a lower number of
granulomas than those infected with the WT strain (Fig. 5). A similar distribution of
lesions was observed when mice were infected intravenously (date not shown). There-
fore, PCN silencing diminishes the ability of P. brasiliensis to cause disease. The fact that
PCN enhances fungal pathogenicity suggests that PCN is a P. brasiliensis virulence
factor.
PCN is a contributory virulence factor in P. brasiliensis yeasts. Since PCN
silencing reduces P. brasiliensis resistance to macrophage killing and decreases fungal
pathogenicity, we evaluated whether PCN is important in P. brasiliensis virulence by
comparing the mortality curves, obtained over an 80-day period, of mice infected with
FIG 3 Effect of PCN silencing on the morphological transition of P. brasiliensis cells. EV, AsPCN1, AsPCN2,
and AsPCN3 strains were grown in solid BHI medium or liquid DMEM at 25°C. The images represent the
results of ﬂuorescence microscopy of calcoﬂuor white-stained cells from the various P. brasiliensis strains
cultured for 1 and 10 days in DMEM. Bars correspond to 50 m.
PCN Silencing Affects P. brasiliensis Virulence ®
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PCN-silenced or WT yeasts. Figure 6 shows that, at 50 days postinfection, all animals
infected with the WT strain had died. In sharp contrast, the survival rates in mice
infected with AsPCN2, AsPCN1, and AsPCN3 were 60%, 75%, and 85%, respectively, and
these survival rates were stable from day 50 to day 80 of observation. These data show
that PCN silencing affects P. brasiliensis pathogenesis and that PCN acts as a contrib-
utory virulence factor.
DISCUSSION
The development of a paracoccidioidomycosis infection is closely related to fungus
virulence and pathogenicity (7, 12), as well as to host susceptibility and immune status
(2, 11). Several studies have shown that P. brasiliensis genes may be associated with
fungal virulence (21–25) and thereby inﬂuence the host immune response (18–20,
26–31). In addition to participating in fungal morphogenesis, an important role was
recently attributed to PCN in P. brasiliensis infection (15, 16). The results of that study
encouraged us to generate yeast strains in which the PCN gene was silenced and to use
FIG 4 Effect of PCN silencing on P. brasiliensis interaction with host cells. WT, EV, AsPCN1, AsPCN2, and
AsPCN3 P. brasiliensis yeasts were grown in DMEM at 37°C for 5 days. (A) The yeast cells were incubated
for 2 h with A549 human lung epithelial cells; after washing, the number of adhering yeasts was
estimated by CFU count. (B) The yeasts were incubated for 4 h with murine peritoneal macrophages; after
macrophage lysis, the recovered yeast cells were counted by optical microscopy, using Neubauer
chambers. (C) CFU recovered from the lysate of murine peritoneal macrophages after 48 h of coculture
at 37°C with WT, AsPCN1, AsPCN2, or AsPCN3 P. brasiliensis cells. The CFU count gives an estimate of the
resistance of the yeast strains to macrophage killing. ***, signiﬁcant difference from the WT strain (P 
0.0001).
Fernandes et al. ®
July/August 2017 Volume 8 Issue 4 e00537-17 mbio.asm.org 6
 
m
bio.asm
.org
 o
n
 N
ovem
ber 28, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
these strains to deﬁne the role of PCN in P. brasiliensis biology and pathogenesis. In
comparison to WT yeast, the PCN-silenced yeast strains formed cellular aggregates and
had an inability to make the yeast-to-mycelium transition as well as greater suscepti-
bility to the fungicidal activity of macrophages. Moreover, infection of mice with the
PCN-silenced yeast strains resulted in a mild infection and low mortality rates. These
results clearly show that PCN is involved in the pathogenicity and virulence of P. brasil-
iensis.
Cultures of the PCN-silenced yeast strains, as well as the WT yeast strain, exhibited
similar cell viability and growth results; however, in spite of this, the PCN-silenced yeast
cells were very noticeably agglomerated compared to their WT counterparts. These
data are consistent with other reported PCN features: (i) PCN in P. brasiliensis is colocalized
with the -1,4-GlcNAc homopolymer in the yeast budding sites; and (ii) PCN has
N-acetyl--D-glucosaminidase activity, which is known to be important in the mecha-
nism of cell wall remodeling (15). The yeast aggregation noted in the AsPCN strains is
similar to that reported for fungi that had a deletion of the gene encoding chitinase,
e.g., CST1 in Saccharomyces cerevisiae (32) and CTH3 in Candida albicans (33).
Because the fungal morphological transition requires coordinated cell wall remod-
eling (34) and this process appeared to be disrupted in the PCN-silenced yeast strains,
we investigated the transition process in the mutant yeast strains. As predicted, the
process was blocked in the PCN-silenced yeast strains, whose morphology became
more compatible with that of pseudohyphae, a fungal form that is unusual for
P. brasiliensis. Because we did not obtain the PCN-silent yeast strains in mycelium form,
we could not verify the effect of PCN deﬁciency on the transition to the parasite form
FIG 5 Fungal burden and tissue injury in mice infected intranasally with PCN-silenced P. brasiliensis yeast strains. BALB/c mice were
inoculated intranasally with 2 106 WT, AsPCN1, AsPCN2, or AsPCN3 P. brasiliensis cells. Analyses were performed at 30 days postinfection.
(A) Number of recovered CFU/g pulmonary tissue. ***, signiﬁcant difference from WT strain-infected animals (P  0.0001). ND, not
detected. (B) The lung was ﬁxed in formalin, embedded in parafﬁn, cut into 5-m-thick sections, and stained with hematoxylin and eosin
(H&E) for light-microscopy analysis. The black line scale bar corresponds to 400 m.
FIG 6 Survival curves of mice infected intravenously with PCN-silenced P. brasiliensis yeast strains. Male
BALB/c mice were infected with 1  107 WT, AsPCN1, AsPCN2, or AsPCN3 P. brasiliensis cells. The mice
were monitored daily for survival over an 80-day period following infection. Mouse survival is expressed
as a percentage. *, signiﬁcant difference from mice infected with the WT strain (P  0.05).
PCN Silencing Affects P. brasiliensis Virulence ®
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(yeast), a process that is important in the virulence of dimorphic fungi (35). These
results suggest that PCN plays an important role in P. brasiliensis cell morphology.
The adherence of PCN-silenced yeast strains to lung epithelial cells was not affected.
However, PCN silencing did enhance the yeast’s susceptibility to macrophage effector
function. This is relevant because macrophages constitute fungal replication niches and
provide the chief mechanism of defense against P. brasiliensis infection (36). Taken
together, these effects of PCN favoring fungal growth support the concept of PCN
being a P. brasiliensis virulence factor. Furthermore, mice infected with PCN-silenced
yeast strains had a lower pulmonary fungal burden, milder tissue lesions, and lower
mortality rates than mice infected with a WT strain of P. brasiliensis. Since the disease
outcomes were similar in mice inoculated either intravenously or intranasally with
PCN-silenced yeast strains, it can be concluded that the infection route does not explain
the milder disease caused by the AsPCN mutant strains. Taken together, these data
obtained in the experimental PCM model strongly support the concept that PCN is
involved in fungal virulence.
Virulence factors may be targets in the immune response (37), drawing attention to
the fact that virulence inﬂuences host immunity (38). Consistent with this, the work of
Alegre et al. (18) showed that recombinant PCN, administered prophylactically to mice,
induced a host protective immunity manifested by a decrease in both tissue fungal load
and granuloma occurrence. Success in the use of virulence factors as vaccine antigens
is consistent with the principle that the immune response can be altered by reducing
or nullifying the virulence of certain microbes (39). Because we have previously
reported that the subcutaneous injection of recombinant PCN in mice exerts a pro-
phylactic or therapeutic effect against P. brasiliensis infection (18, 19), it might be
expected that the PCN-silenced fungi would cause a more severe manifestation of
experimental disease. We observed the opposite, which led us to suppose that the slow
endogenous PCN release by the infecting yeast was not sufﬁcient to maintain an immu-
nomodulatory effect; conversely, this effect was attained when a concentrated aliquot
of exogenous PCN was subcutaneously administered to the host. It is possible that,
whereas endogenous PCN would act directly on the infecting fungi, positively inﬂu-
encing virulence and pathogenicity, injected PCN would interact directly with host
immune cells, causing their activation, production of inﬂammatory mediators, and the
development of a protective response to P. brasiliensis.
Another relevant issue for the concept of virulence factors is that they may function
as essential (requisite) or relative (contributory) molecules. Requisite virulence factors
confer pathogenicity and the ability to cause disease, whereas contributory virulence
factors modify disease magnitude and extension (38). On the basis of the effects of
gene silencing of PCN in P. brasiliensis, including increased susceptibility to the fungi-
cidal activity of macrophages, reduced disease severity in mice, reduced tissue fungal
load and injury, and a lower mouse mortality rate, we conclude that PCN is a contrib-
utory virulence factor for the establishment of P. brasiliensis infection.
MATERIALS AND METHODS
Mice and ethics statement. Male BALB/c mice that were 6 to 8 weeks of age, obtained from the
Animal Facility of Ribeirão Preto Campus, were maintained in the animal facility of the Molecular and
Cellular Biology Department, Ribeirão Preto School of Medicine, University of São Paulo. All animals were
acclimated to the facility for 1 week before the study start. Animals were housed in individually ventilated
cages in light-tight cabinets and were maintained at 20 to 22°C using a 12-h light–12-h dark cycle, under
optimized hygienic conditions, and with ad libitum access to chow and water. Animal procedures were
conducted in accordance with the ethical principles of animal research adopted by the Brazilian Society
of Laboratory Animal Science and approved by the Ethical Committee for Ethics in Animal Research
(CETEA) of the Ribeirão Preto School of Medicine, University of São Paulo, under protocol 60/2016.
Microorganism strains. P. brasiliensis strain 18 (WT) and PCN-downregulated strains (AsPCN) were
maintained in brain heart infusion (BHI) solid or liquid media (Sigma-Aldrich, St. Louis, MO, USA)
supplemented with 1% glucose and ampicillin (100 g/ml) or Dulbecco’s modiﬁed Eagle’s medium
(DMEM) (Sigma-Aldrich) at 37°C on a mechanical shaker (200 rpm). Bacterial cells were maintained in
Luria-Bertani (LB) medium supplemented with the appropriate antibiotics or left unsupplemented.
Escherichia coli DH5 was used as the host for plasmid ampliﬁcation and cloning. Agrobacterium
Fernandes et al. ®
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tumefaciens strain LBA1100 (40) was used as the recipient for the binary vectors. The time period and
temperature of the incubation and the use of antibiotics are described below.
Construction of P. brasiliensis PCN antisense RNA (AsPCN) strains. To obtain a PCN-silenced
P. brasiliensis strain, we used the antisense RNA (AsRNA) strategy and Agrobacterium tumefaciens-
mediated transformation (ATMT), as described previously (13, 21, 41). Brieﬂy, two regions within the
second exon of the PCN gene (18) which comprise nucleotides between positions 159 and 527 (AS1) and
positions 288 and 527 (AS2) were ampliﬁed using a high-ﬁdelity proofreading DNA polymerase
(NZYTech, Lisbon, Portugal) and AsPCNF1-AsPCNR and AsPCNF2-AsPCNR primers (Sigma-Aldrich) (see
Table S1 in the supplemental material), respectively. Both AS1 and AS2 were inserted individually into the
pCR35-RHO2 vector under the control of the Rho (Ras homology) GTPase 2 (RHO2) promoter region from
P. brasiliensis. The pCR35-RHO2 vectors carrying AS1 or AS2 were used for AsRNA cassette ampliﬁcation
and were inserted individually within the transfer DNA (T-DNA) of pUR5750 parental binary vector. These
vectors were used to transform A. tumefaciens LBA1100. Transformants were selected in LB medium
containing 100 g/ml kanamycin and were used thereafter for transformation of P. brasiliensis. To
achieve this, A. tumefaciens carrying the pUR5750 binary vector containing AsRNA cassettes was
cocultured with P. brasiliensis yeast at a 1:10 ratio on sterile Hybond N ﬁlters (GE Healthcare Life Science,
Pittsburgh, PA) in a solid medium IM (induction medium) at 28°C for 3 days. After cocultivation, the
membranes were transferred to liquid BHI medium containing cefotaxime (200 g/ml). The cells in
suspension were incubated for 48 h at 200 rpm at 37°C before being transferred to the selective BHI
medium containing hygromycin B (100 g/ml) and cefotaxime (100 g/ml) at 37°C for 15 days.
Mitotic stability and detection of the hygromycin resistance gene (HPH). Hygromycin B-resistant
transformants were randomly selected and serially transferred to nonselective BHI solid medium for three
ﬁnal times. Then, transformants were serially inoculated on plates with nonselective and selective
medium (100 g/ml) for three consecutive rounds to examine mitotic stability. In order to conﬁrm the
presence of T-DNA in the selected AsPCN mutant strains, these transformants were evaluated by PCR
analysis by amplifying the hygromycin B resistance gene (HPH) with HPHF and HPHR primers (Sigma-
Aldrich) (Table S1), according to the procedure described by Torres et al. (23). The WT strain was used
as the negative control, and pUR5750 parental binary vector was used as the positive control. The
reaction products were analyzed on a 1% agarose gel stained with SYBR Safe DNA gel stain (Thermo
Fisher Scientiﬁc Inc., Waltham, MA) and visualized with UV light.
RNA extraction and cDNA synthesis. Total RNA was extracted using TRIzol (Thermo Fisher Scien-
tiﬁc) from WT, AsPCN1, AsPCN2, and AsPCN3 yeast cells grown in DMEM (Sigma-Aldrich) at 37°C for 96 h
during the early exponential phase. Yeast cells were collected by centrifugation at 3,000  g at 25°C for
5 min and washed with 1 ml TE buffer (10 mM Tris-HCl, 1 mM EDTA [pH 7.5]) mixed in diethyl
pyrocarbonate (DEPC) ultrapure water (Sigma-Aldrich). Pelleted yeast cells were transferred to a mortar,
liquid nitrogen was added, and cells were disrupted with a pestle. After this process, the RNA was puriﬁed
according to the TRIzol protocol. The quality of the puriﬁed RNA was assessed by electrophoretic analysis
on a 2% agarose gel stained with SYBR Safe DNA gel stain and by the use of a NanoDrop 1000 instrument
(Thermo Fisher Scientiﬁc). The absence of contaminating chromosomal DNA was conﬁrmed, after the
treatment of the RNA with DNase I (Thermo Fisher Scientiﬁc), by the absence of the -tubulin gene as
shown by PCR. The cDNA was synthesized from 1 g RNA using Moloney murine leukemia virus (MMLV)
reverse transcriptase, according to the instructions of the manufacturer (Promega, Fitchburg, WI).
Quantitative real-time PCR (qRT-PCR). Real-time PCR was carried out by mixing the cDNA derived
from each sample with platinum SYBR green pPCR SuperMix-UDG with ROX, according to the instruc-
tions of the manufacturer (Thermo Fisher Scientiﬁc). PCR ampliﬁcation was performed using a CFX96
real-time PCR detection system (Bio-Rad, Hercules, USA). The sequences of the RT-PCNF and RT-PCNR
primers used to detect the PCN mRNA expression levels are shown in Table S1. -Tubulin (42) and -actin
(sequence identiﬁer [ID] reference XM_010763641.1) genes were used as references, and the relevant
primer sequences are also shown in Table S1. Melting curve analysis was carried out after the ampliﬁ-
cation phase to eliminate the possibility of nonspeciﬁc ampliﬁcation or primer-dimer formation. The PCN
gene relative expression levels were quantiﬁed using the threshold cycle (ΔΔCT) method (2ΔCT) and
normalized to -actin and -tubulin as follows: ΔCT  CTPCN value  average of CT-tubulin and CT-actin
values. All experiments were performed using biological and experimental triplicates.
N-Acetyl--D-glucosaminidase activity assay. N-Acetyl--D-glucosaminidase activity was assayed
through reaction with --nitrophenol-N-acetylglucosamine (NPGlcNAc) (Sigma-Aldrich) and detection
of -nitrophenol formation (15). Brieﬂy, 50 l of cell lysate (5 g of total protein) derived from the WT,
AsPCN1, AsPCN2, and AsPCN3 strains were prepared according to the method reported by Fernandes et
al. (26) and was added individually to 350 l of 0.1 M sodium acetate (pH 5.5) and 100 l of 5 mM
NPGlcNAc. After incubation for 18 h at 37°C, the mixture was added to 0.5 M sodium carbonate (1 ml).
The amount of released -nitrophenol was determined by measuring the solution’s absorbance at
405 nm. As a negative control, cell culture medium was used.
Western blotting. The Western blot analysis was performed by the use of 12% SDS-PAGE to separate
the soluble components of P. brasiliensis yeasts from strains WT, EV, AsPCN1, AsPCN2, and AsPCN3, grown
in DMEM (Sigma-Aldrich) at 37°C for 96 h (exponential phase). The components were electrotransferred
to a polyvinylidene diﬂuoride (PVDF) membrane (Hybond membranes [Amersham; GE Healthcare]) (pore
size, 0.45 m). Thereafter, membranes were blocked with Tris-buffered saline–Tween 20 (TBS-T) (20 mM
Tris-HCl, 150 mM NaCl, 0.1% [vol/vol] Tween 20 [pH 7.6]) containing 3% bovine serum albumin (BSA) for
4 h at 25°C. The membrane was then incubated with anti-PCN IgY polyclonal antibody diluted 1:3,000 in
TBS-T or with anti--actin mouse monoclonal antibody IgG (Santa Cruz Biotechnology Inc., Dallas, TX,
USA), also diluted 1:5,000 in TBS-T. The membrane was washed ﬁve times with TBS-T and incubated for
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1 h at room temperature with the anti-IgY secondary antibody conjugated to peroxidase (Sigma-Aldrich)
diluted 1:1,000 or with anti-IgG secondary antibody conjugated to peroxidase (Sigma-Aldrich) diluted
1:3,000 in TBS-T containing 1% BSA. After ﬁve washes with TBS-T were performed, the membrane was
immersed in a fresh mixture of DAB peroxidase substrate kit SK4100 (Vector Laboratories, Burlingame,
CA). Distilled water was used to stop the reaction. The images were analyzed ofﬂine using the software
ImageJ (W. S. Rasband, National Institutes of Health, Bethesda, MD; https://imagej.nih.gov/ij/), which
generated graphic representations of the staining intensity of the PCN band (expressed in percentages),
after normalization with -actin.
Growth curve and cell viability. WT, AsPCN1, AsPCN2, and AsPCN3 yeasts were cultured in DMEM
(Sigma-Aldrich) at 37°C with aeration on a mechanical shaker (200 rpm). Growth of the organisms was
assessed by cell counting using optical microscopy and a Neubauer chamber at 0, 36, 72, 96, 120, 144,
168, 192, and 216 h until the stationary-growth phase was reached. All cultures were performed with an
initial concentration of 1  105 cells/ml. At the time points of 0 and 192 h, a sample was harvested for
cell viability analysis by staining with diacetate ﬂuorescein-ethidium bromide, as described by Calich
et al. (43).
Morphological transition. WT, AsPCN1, AsPCN2, and AsPCN3 yeasts were cultured at 25°C in DMEM
(Sigma-Aldrich). Aliquots of the DMEM cultures were harvested at 1 and 10 days, ﬁxed in 3.7%
formaldehyde at 25°C for 45 min, and stained with calcoﬂuor white (50 g/ml) for observation with a
ﬂuorescence microscope.
Assay of adherence of P. brasiliensis yeasts to lung epithelial cells. The assay to assess adherence
of yeast to host cells was carried out as described by Hernández et al. (22), with small modiﬁcations. The
monolayers of A549 cells (1  106 cells/well) were cocultured for 2 h with WT, AsPCN1, AsPCN2, and
AsPCN3 strains (2  105 cells) at 37°C in a 5% CO2 atmosphere. The fungal inoculum suspension was
obtained from the supernatant of liquid cultures that were allowed to settle, without shaking, for 10 min
at room temperature. This process decants the fungal aggregates, providing a nonaggregated inoculum.
The supernatants from the cultures, containing nonadherent yeast cells, were discarded, the monolayers
were lysed, and the resulting suspension of adherent yeast cells was plated onto solid BHI medium
supplemented with 1% glucose. The percentage of adherent yeast cells was estimated from the ratio of
the number of CFU obtained from each well to the number of CFU obtained from the control wells,
which contained only yeast cells. This assay was performed in triplicate in three independent experi-
ments.
Assay of fungal phagocytosis and killing by macrophages. Yeast cells from WT, AsPCN1, AsPCN2,
and AsPCN3 strains, grown in DMEM (Sigma-Aldrich) at 37°C for 96 h (exponential phase), were
cocultured with macrophages obtained from the peritoneal cavity of male BALB/c mice which had been
previously injected with 1.0 ml of 3% sterile sodium thioglycollate (Sigma-Aldrich), according to a
protocol adopted by Freitas et al. (17). The fungal inoculum was prepared as described for the previous
item. To assess phagocytic activity, macrophages (1  106/well) were plated into a 24-well microplate
(BD Biosciences) and incubated with yeast cells (2  105 cells/well) for 1 h at 25°C (yeast-to-macrophage
ratio of 1:5). After 4 h at 37°C in a 5% CO2 atmosphere, the coculture supernatant was discarded. The
macrophage monolayers were lysed with sterile ultrapure water, and yeast cells were harvested for
counting using a Neubauer chamber in optical microscopy. To estimate the macrophage fungicidal
activity, viable yeast cells were cocultured with macrophages at 37°C in a 5% CO2 atmosphere for 4 h.
The culture supernatant was discarded, and the cells were gently rinsed with phosphate-buffered saline
(PBS) and incubated in DMEM (Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS; HyClone)
at 37°C in a 5% CO2 atmosphere. After 48 h of incubation, the culture supernatant was discarded and
macrophages were lysed using sterile ultrapure water. The cell lysate was serially diluted and cultured for
10 days at 37°C in solid BHI medium supplemented with 1% glucose. Analyses were performed by
determining the number of CFU.
Tissue fungal burden and lung histopathology. Male BALB/c mice were infected with yeast cells
from WT, AsPCN1, AsPCN2, and AsPCN3 strains (5 animals per group) grown in DMEM (Sigma-Aldrich)
supplemented with 4% fetal bovine serum (FBS) at 37°C for 96 h (exponential phase). Infections were
performed by either intranasal (i.n.) or intravenous (i.v.) delivery of 2  106 or 1  106 yeast cells per
animal, respectively. At 30 days postinfection, the lung, liver, and spleen fungal loads were determined
by CFU counting, as described previously (26, 44, 45). The histopathological analysis of the lungs was
performed according to a protocol adopted by Fernandes et al. (26).
Generation of the survival curve. Male BALB/c mice (eight animals/group) were intravenously
inoculated with 1 107 viable yeast cells from WT, AsPCN1, AsPCN2, and AsPCN3 strains grown in DMEM
(Sigma-Aldrich) for 96 h (exponential phase) at 37°C. The mice were monitored daily for survival over an
80-day period following infection.
Statistical analysis. GraphPad Prism software (GraphPad Software, Inc., La Jolla, CA) was used for
statistical analysis. The results are expressed as means  standard errors of the means (SEM). All data are
representative of results from at least three independent assays. Statistical differences among the means
of data from the different experimental groups were determined using one-way analysis of variance
followed by Bonferroni’s posttest. Differences with P values of 0.05 were considered statistically
signiﬁcant.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00537-17.
TABLE S1, DOCX ﬁle, 0.01 MB.
Fernandes et al. ®
July/August 2017 Volume 8 Issue 4 e00537-17 mbio.asm.org 10
 
m
bio.asm
.org
 o
n
 N
ovem
ber 28, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
ACKNOWLEDGMENTS
We thank Sandra M. O. Thomaz, Érica Vendruscolo, and Wander Cosme Ribeiro for
technical support and Domingos Soares de Souza Filho for expert animal care. We
thank Roberta R. Costa Rosales for technical support in microscopy. We also thank Ana
Oliveira-Coelho and Jéssica A. R. Gomes for the support on fungal gene modulation
methodology.
This work had ﬁnancial support from the following agencies: Fundação de Amparo
à Pesquisa do Estado de São Paulo – FAPESP (2016/00629-4, 2014/05359-0, 2012/
08552-0, 2014/22561-7, 2012/09611-0, 2016/04877-2, 2016/60642-2, and 2013/04088-
0); Conselho Nacional de Desenvolvimento Cientíﬁco e Tecnológico – CNPq (150036/
2014-0, 477161/2008-1, and 475357/2013-2); Financiadora de Estudos e Projetos –
FINEP (0110045900); Ministry of Education and Science – Fundação para a Ciência e a
Tecnologia – FCT (SFRH/BPD/96176/2013 and IF/00735/2014).
REFERENCES
1. Colombo AL, Tobón A, Restrepo A, Queiroz-Telles F, Nucci M. 2011.
Epidemiology of endemic systemic fungal infections in Latin America.
Med Mycol 49:785–798. https://doi.org/10.3109/13693786.2011.577821.
2. Coutinho ZF, da Silva D, Lazera M, Petri V, Oliveira RM, Sabroza PC, Wanke
B. 2002. Paracoccidioidomycosis mortality in Brazil (1980–1995). Cad Saude
Publica 18:1441–1454. https://doi.org/10.1590/S0102-311X2002000500037.
3. Restrepo A, Benard G, de Castro CC, Agudelo CA, Tobón AM. 2008.
Pulmonary paracoccidioidomycosis. Semin Respir Crit Care Med 29:
182–197. https://doi.org/10.1055/s-2008-1063857.
4. Laniado-Laborín R. 2007. Coccidioidomycosis and other endemic myco-
ses in Mexico. Rev Iberoam Micol 24:249–258. https://doi.org/10.1016/
S1130-1406(07)70051-7.
5. Teixeira MDM, Theodoro RC, Derengowski LDS, Nicola AM, Bagagli E,
Felipe MS. 2013. Molecular and morphological data support the exis-
tence of a sexual cycle in species of the genus Paracoccidioides. Eu-
karyot Cell 12:380–389. https://doi.org/10.1128/EC.05052-11.
6. Teixeira MM, Theodoro RC, de Carvalho MJ, Fernandes L, Paes HC, Hahn
RC, Mendoza L, Bagagli E, San-Blas G, Felipe MS. 2009. Phylogenetic
analysis reveals a high level of speciation in the Paracoccidioides genus.
Mol Phylogenet Evol 52:273–283. https://doi.org/10.1016/j.ympev.2009
.04.005.
7. San-Blas G, Niño-Vega G, Iturriaga T. 2002. Paracoccidioides brasiliensis
and paracoccidioidomycosis: molecular approaches to morphogenesis,
diagnosis, epidemiology, taxonomy and genetics. Med Mycol 40:
225–242. https://doi.org/10.1080/mmy.40.3.225.242.
8. Borges-Walmsley MI, Chen D, Shu X, Walmsley AR. 2002. The pathobi-
ology of Paracoccidioides brasiliensis. Trends Microbiol 10:80–87.
https://doi.org/10.1016/S0966-842X(01)02292-2.
9. Brummer E, Castaneda E, Restrepo A. 1993. Paracoccidioidomycosis: an
update. Clin Microbiol Rev 6:89–117. https://doi.org/10.1128/CMR.6.2.89.
10. Franco M, Montenegro MR, Mendes RP, Marques SA, Dillon NL, Mota NG.
1987. Paracoccidioidomycosis: a recently proposed classiﬁcation of its
clinical forms. Rev Soc Bras Med Trop 20:129–132. https://doi.org/10
.1590/S0037-86821987000200012.
11. Robledo MA, Graybill JR, Ahrens J, Restrepo A, Drutz DJ, Robledo M.
1982. Host defense against experimental paracoccidioidomycosis. Am
Rev Respir Dis 125:563–567. https://doi.org/10.1164/arrd.1982.125.5.563.
12. San-Blas G, San-Blas F. 1977. Paracoccidioides brasiliensis: cell wall struc-
ture and virulence. A review. Mycopathologia 62:77–86. https://doi.org/
10.1007/BF01259396.
13. Almeida AJ, Carmona JA, Cunha C, Carvalho A, Rappleye CA, Goldman
WE, Hooykaas PJ, Leão C, Ludovico P, Rodrigues F. 2007. Towards a
molecular genetic system for the pathogenic fungus Paracoccidioides
brasiliensis. Fungal Genet Biol 44:1387–1398. https://doi.org/10.1016/j
.fgb.2007.04.004.
14. Coltri KC, Casabona-Fortunato AS, Gennari-Cardoso ML, Pinzan CF, Ruas
LP, Mariano VS, Martinez R, Rosa JC, Panunto-Castelo A, Roque-Barreira
MC. 2006. Paracoccin, a GlcNAc-binding lectin from Paracoccidioides
brasiliensis, binds to laminin and induces TNF-alpha production by
macrophages. Microbes Infect 8:704–713. https://doi.org/10.1016/j
.micinf.2005.09.008.
15. dos Reis Almeida FB, de Oliveira LL, Valle de Sousa M, Roque Barreira MC,
Hanna ES. 2010. Paracoccin from Paracoccidioides brasiliensis; puriﬁca-
tion through afﬁnity with chitin and identiﬁcation of N-acetyl-beta-D-
glucosaminidase activity. Yeast 27:67–76. https://doi.org/10.1002/yea
.1731.
16. Ganiko L, Puccia R, Mariano VS, Sant’Anna OA, Freymüller E, Roque-
Barreira MC, Travassos LR. 2007. Paracoccin, an N-acetyl-glucosamine-
binding lectin of Paracoccidioides brasiliensis, is involved in fungal
growth. Microbes Infect 9:695–703. https://doi.org/10.1016/j.micinf.2007
.02.012.
17. Freitas MS, Oliveira AF, da Silva TA, Fernandes FF, Gonçales RA, Almeida
F, Roque-Barreira MC. 2016. Paracoccin induces M1 polarization of mac-
rophages via interaction with TLR4. Front Microbiol 7:1003. https://doi
.org/10.3389/fmicb.2016.01003.
18. Alegre AC, Oliveira AF, Dos Reis Almeida FB, Roque-Barreira MC, Hanna
ES. 2014. Recombinant paracoccin reproduces the biological properties
of the native protein and induces protective Th1 immunity against
Paracoccidioides brasiliensis infection. PLoS Negl Trop Dis 8:e2788.
https://doi.org/10.1371/journal.pntd.0002788.
19. Alegre-Maller AC, Mendonça FC, da Silva TA, Oliveira AF, Freitas MS,
Hanna ES, Almeida IC, Gay NJ, Roque-Barreira MC. 2014. Therapeutic
administration of recombinant paracoccin confers protection against
Paracoccidioides brasiliensis infection: involvement of TLRs. PLoS Negl
Trop Dis 8:e3317. https://doi.org/10.1371/journal.pntd.0003317.
20. Marques AF, da Silva MB, Juliano MA, Munhõz JE, Travassos LR, Taborda
CP. 2008. Additive effect of P10 immunization and chemotherapy in
anergic mice challenged intratracheally with virulent yeasts of Paracoc-
cidioides brasiliensis. Microbes Infect 10:1251–1258. https://doi.org/10
.1016/j.micinf.2008.07.027.
21. Almeida AJ, Cunha C, Carmona JA, Sampaio-Marques B, Carvalho A,
Malavazi I, Steensma HY, Johnson DI, Leão C, Logarinho E, Goldman GH,
Castro AG, Ludovico P, Rodrigues F. 2009. Cdc42p controls yeast-cell
shape and virulence of Paracoccidioides brasiliensis. Fungal Genet Biol
46:919–926. https://doi.org/10.1016/j.fgb.2009.08.004.
22. Hernández O, Almeida AJ, Gonzalez A, Garcia AM, Tamayo D, Cano LE,
Restrepo A, McEwen JG. 2010. A 32-kilodalton hydrolase plays an im-
portant role in Paracoccidioides brasiliensis adherence to host cells and
inﬂuences pathogenicity. Infect Immun 78:5280–5286. https://doi.org/
10.1128/IAI.00692-10.
23. Torres I, Hernandez O, Tamayo D, Muñoz JF, Leitão NP, Jr, García AM,
Restrepo A, Puccia R, McEwen JG. 2013. Inhibition of PbGP43 expression
may suggest that gp43 is a virulence factor in Paracoccidioides brasil-
iensis. PLoS One 8:e68434. https://doi.org/10.1371/journal.pone
.0068434.
24. Menino JF, Saraiva M, Gomes-Rezende J, Sturme M, Pedrosa J, Castro AG,
Ludovico P, Goldman GH, Rodrigues F. 2013. P. brasiliensis virulence is
affected by SconC, the negative regulator of inorganic sulfur assimila-
tion. PLoS One 8:e74725. https://doi.org/10.1371/journal.pone.0074725.
25. Tamayo D, Muñoz JF, Lopez Á, Urán M, Herrera J, Borges CL, Restrepo Á,
Soares CM, Taborda CP, Almeida AJ, McEwen JG, Hernández O. 2016.
Identiﬁcation and analysis of the role of superoxide dismutases isoforms
in the pathogenesis of Paracoccidioides spp. PLoS Negl Trop Dis 10:
e0004481. https://doi.org/10.1371/journal.pntd.0004481.
26. Fernandes FF, Oliveira LL, Landgraf TN, Peron G, Costa MV, Coelho-
Castelo AA, Bonato VL, Roque-Barreira MC, Panunto-Castelo A. 2016.
PCN Silencing Affects P. brasiliensis Virulence ®
July/August 2017 Volume 8 Issue 4 e00537-17 mbio.asm.org 11
 
m
bio.asm
.org
 o
n
 N
ovem
ber 28, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
Detrimental effect of fungal 60-kDa heat shock protein on experimental
Paracoccidioides brasiliensis infection. PLoS One 11:e0162486. https://
doi.org/10.1371/journal.pone.0162486.
27. Muñoz JE, Luft VD, Amorim J, Magalhães A, Thomaz L, Nosanchuk JD,
Travassos LR, Taborda CP. 2014. Immunization with P10 peptide in-
creases speciﬁc immunity and protects immunosuppressed BALB/c mice
infected with virulent yeasts of Paracoccidioides brasiliensis. Mycopatho-
logia 178:177–188. https://doi.org/10.1007/s11046-014-9801-1.
28. Fernandes VC, Martins EM, Boeloni JN, Coitinho JB, Serakides R, Goes
AM. 2011. Additive effect of rPb27 immunization and chemotherapy in
experimental paracoccidioidomycosis. PLoS One 6:e17885. https://doi
.org/10.1371/journal.pone.0017885.
29. Fernandes VC, Martins EM, Boeloni JN, Coitinho JB, Serakides R, Goes
AM. 2011. The combined use of Paracoccidioides brasiliensis Pb40 and
Pb27 recombinant proteins enhances chemotherapy effects in experi-
mental paracoccidioidomycosis. Microbes Infect 13:1062–1072. https://
doi.org/10.1016/j.micinf.2011.06.004.
30. Reis BS, Fernandes VC, Martins EM, Serakides R, Goes AM. 2008. Protec-
tive immunity induced by rPb27 of Paracoccidioides brasiliensis. Vaccine
26:5461–5469. https://doi.org/10.1016/j.vaccine.2008.07.097.
31. Taborda CP, Juliano MA, Puccia R, Franco M, Travassos LR. 1998. Map-
ping of the T-cell epitope in the major 43- kilodalton glycoprotein of
Paracoccidioides brasiliensis which induces a Th-1 response protective
against fungal infection in BALB/c mice. Infect Immun 66:786–793.
32. Kuranda MJ, Robbins PW. 1991. Chitinase is required for cell separation
during growth of Saccharomyces cerevisiae. J Biol Chem 266:
19758–19767.
33. Dünkler A, Walther A, Specht CA, Wendland J. 2005. Candida albicans
CHT3 encodes the functional homolog of the Cts1 chitinase of Saccha-
romyces cerevisiae. Fungal Genet Biol 42:935–947. https://doi.org/10
.1016/j.fgb.2005.08.001.
34. Bastos KP, Bailão AM, Borges CL, Faria FP, Felipe MS, Silva MG, Martins
WS, Fiúza RB, Pereira M, Soares CM. 2007. The transcriptome analysis of
early morphogenesis in Paracoccidioides brasiliensis mycelium reveals
novel and induced genes potentially associated to the dimorphic pro-
cess. BMC Microbiol 7:29. https://doi.org/10.1186/1471-2180-7-29.
35. Rappleye CA, Goldman WE. 2006. Deﬁning virulence genes in the di-
morphic fungi. Annu Rev Microbiol 60:281–303. https://doi.org/10.1146/
annurev.micro.59.030804.121055.
36. Moscardi-Bacchi M, Brummer E, Stevens DA. 1994. Support of Paracoc-
cidioides brasiliensis multiplication by human monocytes or
macrophages: inhibition by activated phagocytes. J Med Microbiol 40:
159–164. https://doi.org/10.1099/00222615-40-3-159.
37. Tang C, Holden D. 1999. Pathogen virulence genes—implications for
vaccines and drug therapy. Br Med Bull 55:387–400. https://doi.org/10
.1258/0007142991902448.
38. Casadevall A, Pirofski L. 2001. Host-pathogen interactions: the attributes
of virulence. J Infect Dis 184:337–344. https://doi.org/10.1086/322044.
39. Brubaker RR. 1985. Mechanisms of bacterial virulence. Annu Rev Micro-
biol 39:21–50. https://doi.org/10.1146/annurev.mi.39.100185.000321.
40. Beijersbergen A, Dulk-Ras AD, Schilperoort RA, Hooykaas PJ. 1992. Con-
jugative transfer by the virulence system of Agrobacterium tumefaciens.
Science 256:1324–1327. https://doi.org/10.1126/science.256.5061.1324.
41. Menino JF, Almeida AJ, Rodrigues F. 2012. Gene knockdown in Paracoc-
cidioides brasiliensis using antisense RNA. Methods Mol Biol 845:
187–198. https://doi.org/10.1007/978-1-61779-539-8_12.
42. Goldman GH, dos Reis Marques E, Duarte Ribeiro DC, de Souza Ber-
nardes LA, Quiapin AC, Vitorelli PM, Savoldi M, Semighini CP, de Oliveira
RC, Nunes LR, Travassos LR, Puccia R, Batista WL, Ferreira LE, Moreira JC,
Bogossian AP, Tekaia F, Nobrega MP, Nobrega FG, Goldman MH. 2003.
Expressed sequence tag analysis of the human pathogen Paracoccid-
ioides brasiliensis yeast phase: identiﬁcation of putative homologues of
Candida albicans virulence and pathogenicity genes. Eukaryot Cell
2:34–48. https://doi.org/10.1128/EC.2.1.34-48.2003.
43. Calich VL, Purchio A, Paula CR. 1979. A new ﬂuorescent viability test for
fungi cells. Mycopathologia 66:175–177. https://doi.org/10.1007/BF0
0683967.
44. de Oliveira LL, Coltri KC, Cardoso CR, Roque-Barreira MC, Panunto-
Castelo A. 2008. T helper 1-inducing adjuvant protects against experi-
mental paracoccidioidomycosis. PLoS Negl Trop Dis 2:e183. https://doi
.org/10.1371/journal.pntd.0000183.
45. Peraçoli MT, Kurokawa CS, Calvi SA, Mendes RP, Pereira PC, Marques SA,
Soares AM. 2003. Production of pro- and anti-inﬂammatory cytokines by
monocytes from patients with paracoccidioidomycosis. Microbes Infect
5:413–418. https://doi.org/10.1016/S1286-4579(03)00040-6.
Fernandes et al. ®
July/August 2017 Volume 8 Issue 4 e00537-17 mbio.asm.org 12
 
m
bio.asm
.org
 o
n
 N
ovem
ber 28, 2017 - Published by 
m
bio.asm
.org
D
ow
nloaded from
 
